Related Experiment Videos

[Syndrome of cholesterol crystal embolism: clinical case]

Claudia Mandolini1, Massimo Trappolini, Andrea Celestini

  • 1Scuola di Specializzazione in Medicina Interna II, Università degli Studi La Sapienza di Roma.

Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna
|May 13, 2003
PubMed

Insights

Cholesterol crystal embolization syndrome, a complication of cardiovascular procedures, causes multiorgan issues. Early identification and prophylactic measures are crucial due to its poor prognosis and high mortality.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Pathology

Background:

  • Cholesterol crystal embolization syndrome (CCES) is a serious complication of invasive cardiovascular procedures and treatments.
  • It arises from dislodged atheromatous plaque material obstructing small arteries.

Observation:

  • A 62-year-old male with hypertension and smoking history developed multiorgan dysfunction (gastrointestinal, neuromuscular, renal) post-aortic aneurysm surgery.
  • The patient presented with hypereosinophilia and elevated inflammatory markers approximately two weeks after intervention.

Findings:

  • Symptoms were transient and attributed to cholesterol crystal embolization.
  • The exact incidence of CCES remains unknown, often leading to missed diagnoses due to delayed clinical presentation and diverse organ involvement.

Implications:

  • CCES has a poor prognosis with high mortality, primarily due to progressive renal failure.
  • Currently, no codified therapeutic regimen exists; prophylactic strategies focusing on high-risk patient identification are recommended.

Related Concept Videos